Applying DEKOIS 2.0 in structure-based virtual screening to probe the impact of preparation procedures and score normalization by Tamer M Ibrahim et al.
Ibrahim et al. Journal of Cheminformatics  (2015) 7:21 
DOI 10.1186/s13321-015-0074-6RESEARCH ARTICLE Open AccessApplying DEKOIS 2.0 in structure-based virtual
screening to probe the impact of preparation
procedures and score normalization
Tamer M Ibrahim1,2, Matthias R Bauer1 and Frank M Boeckler1*Abstract
Background: Structure-based virtual screening techniques can help to identify new lead structures and
complement other screening approaches in drug discovery. Prior to docking, the data (protein crystal structures
and ligands) should be prepared with great attention to molecular and chemical details.
Results: Using a subset of 18 diverse targets from the recently introduced DEKOIS 2.0 benchmark set library, we
found differences in the virtual screening performance of two popular docking tools (GOLD and Glide) when
employing two different commercial packages (e.g. MOE and Maestro) for preparing input data. We
systematically investigated the possible factors that can be responsible for the found differences in selected sets.
For the Angiotensin-I-converting enzyme dataset, preparation of the bioactive molecules clearly exerted the
highest influence on VS performance compared to preparation of the decoys or the target structure. The
major contributing factors were different protonation states, molecular flexibility, and differences in the input
conformation (particularly for cyclic moieties) of bioactives. In addition, score normalization strategies eliminated
the biased docking scores shown by GOLD (ChemPLP) for the larger bioactives and produced a better
performance. Generalizing these normalization strategies on the 18 DEKOIS 2.0 sets, improved the performances
for the majority of GOLD (ChemPLP) docking, while it showed detrimental performances for the majority
of Glide (SP) docking.
Conclusions: In conclusion, we exemplify herein possible issues particularly during the preparation stage of
molecular data and demonstrate to which extent these issues can cause perturbations in the virtual screening
performance. We provide insights into what problems can occur and should be avoided, when generating
benchmarks to characterize the virtual screening performance. Particularly, careful selection of an appropriate
molecular preparation setup for the bioactive set and the use of score normalization for docking with GOLD
(ChemPLP) appear to have a great importance for the screening performance. For virtual screening campaigns,
we recommend to invest time and effort into including alternative preparation workflows into the generation of
the master library, even at the cost of including multiple representations of each molecule.Background
Virtual screening (VS) is a widely applied method in
drug discovery that is used to predict novel bioactives
from large chemical libraries [1–4]. In the last decade a
multitude of successful VS applications have been re-
ported [5–9]. In early-stage drug discovery especially* Correspondence: frank.boeckler@uni-tuebingen.de
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reproduction in any medium, provided the ostructure-based virtual screening (SBVS) has been fre-
quently used to identify new hits [10–14]. SBVS requires
structures of target binding sites to predict potential in-
teractions with ligand molecules. One of the most fre-
quently used SBVS methods is molecular docking, which
is used for docking molecules into the binding pocket to
predict and score energetically favorable ligand binding
modes [15–20].is an Open Access article distributed under the terms of the Creative Commons
org/licenses/by/4.0), which permits unrestricted use, distribution, and
riginal work is properly credited.
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strongly on the respective target properties [1, 21–24].
Different scoring and docking functions consequently
favor different binding situations. To avoid wasting time
and efforts on ineffective VS strategies, it is important to
assess the performance of different VS setups in order to
select the most effective workflow. Screening perform-
ance can be assessed using molecular benchmark sets,
which consist of a set of bioactives and a set of inactive
molecules, also known as decoys [23–25]. The higher
the number of bioactives at the top of the score-ordered
list of screened molecules, the better is the respective
screening performance. Apart from the selection of a
suitable docking tool, the success rate of VS tools de-
pends strongly on various factors, such as the proton-
ation/tautomerization state of the respective protein
binding site residues [26] and of the input molecules
[27–30], as well as the force field-minimized input con-
formation of the respective input molecules [31–35].
In this study, we investigate why and to which extent dif-
ferent protein/ligand preparation procedures affect VS per-
formance by using our recently introduced DEKOIS 2.0
benchmark sets [21, 24, 36]. We test the widely applied
docking tools GOLD and Glide with two comparable set-
tings of input preparation using two different commercial
packages (MOE and Maestro). In addition, we conduct a
systematic in-depth analysis for one example (ACE,
Angiotensin-I-converting enzyme) to evaluate the possible
factors affecting the differences in screening performance
between MOE and Maestro preparations. Interestingly, we
found that the preparation of the bioactives caused a larger
screening performance difference than the preparation of
the decoys set or the target structure. Score normalization
strategies eliminated the bias toward larger molecules in
GOLD docking scores (ChemPLP) for ACE and also pro-
duced better performances in most of the other datasets.Results and discussion
Selection of benchmark sets
To probe the impact of diverse docking setups on VS per-
formance, suitable and diverse test datasets should be
employed. Our recently introduced DEKOIS 2.0 library of-
fers a wide variety of curated high-quality benchmark sets
and is therefore well-suited for compiling a selection of
evaluation kits [21, 24]. We selected 18 DEKOIS 2.0
datasets, each representing a different target class. Our
compilation comprises proteases, kinases, transferases,
oxido-reductases, nuclear receptors, and hydrolases, and de-
scribes various protein-ligand binding situations. This allows
for a comprehensive analysis of performance differences for
various VS setups. A complete list of selected datasets and
the PDB codes of their target structures can be found in the
Supporting Information (Additional file 1: Table S1).Ligand and protein preparation protocols
We aim at comparing the impact of two comparable
preparation setups on VS performance employing two
different preparation packages. Two of the most widely
used applications for input preparation are MOE (Chem-
ical Computing Group) and Maestro (Schrodinger). The
preparation of the data was done at comparable levels of
complexity for both programs, which are described in
more detail in the Methods section. We conducted the
preparation of the dataset (bioactives and decoys sets) by
the LigPrep module in Maestro and the Wash and
Minimize functions of MOE. Similarly, target structures
were prepared by the ProtAssign function in Maestro and
the Prot3D function of MOE.
Impact of different preparation procedures on VS
performance
We utilized the widely used pROC-AUC as a metric for
the screening performance [21, 22, 24]. The pROC curve
is a semi-logarithmic version of the standard linear curve
of the receiver operating characteristics (ROC) [37].
Therefore, pROC curves are emphasizing the recognition
of the early recovered hits when calculating the “area
under the curve” (AUC) [37].
Table 1 shows the impact of different preparation
schemes on docking performances (pROC-AUC) for di-
verse protein targets. Based on these findings, we de-
fined the ΔpROC-AUCprep as:
ΔpROC‐AUCprep ¼ pROC‐AUC MOEð Þ‐pROC‐AUC Maestroð Þ
Because of the heuristic and the stochastic nature of
the docking process in GOLD [31], we defined a “safety
margin” of ±0.05 resulted from the deviation of multiple
runs representing a non-significant change of ΔpROC-
AUCprep, [24], and to avoid over-interpreting small
changes in docking performance.
We observed that VS performances of GOLD for four
of the 18 targets did not significantly differ between the
two preparation schemes (Table 1). The remaining 14
targets showed larger changes. Seven of these targets
(50 %) showed higher pROC-AUC values for Maestro
prepared data, while the other 7 targets (50 %) benefitted
from MOE data preparation. This suggests that the
GOLD screening performance does not generally depend
on a particular preparation scheme. For some examples
the docking performance was affected dramatically by
the different preparation schemes. ACE, ERBB2 and TS
docking results showed relatively large ΔpROC-AUCprep
values, as shown in Table 1.
Despite the fact that the docking process in Glide is
deterministic and multiple docking runs of the same in-
put data yields exactly the same output every time [31],
Table 1 Comparison of docking performances between MOE and Maestro data preparation schemes for diverse protein targets
Target Glide GOLD
Original pROC-AUC Original pROC-AUC
MOE Maestro ΔpROC-AUCprep
a MOE Maestro ΔpROC-AUCprep
ACE 1.73 2.01 −0.28b 1.55 1.25 0.30
ACHE 0.71 0.75 −0.04 0.72 0.72 0.00
ADRB2 0.97 0.89 0.09 0.74 0.65 0.08
CATL 0.72 0.81 −0.09 0.78 0.75 0.04
DHFR 1.12 0.63 0.49c 0.75 0.80 −0.05
ERBB2 2.01 1.80 0.21 1.85 2.12 −0.27
HDAC2 1.74 1.27 0.47 1.02 1.20 −0.18
HIVPR 1.54 1.40 0.13 1.46 1.64 −0.18
HSP90 0.74 0.61 0.14 0.42 0.33 0.10
JAK3 1.32 1.13 0.19 0.78 0.91 −0.14
JNK2 0.66 0.70 −0.04 0.77 0.74 0.03
MDM2 0.84 0.80 0.04 0.51 0.44 0.07
P38 1.79 1.48 0.31 0.49 0.56 −0.07
PI3KG 1.14 1.13 0.01 1.01 0.95 0.06
PNP 1.08 1.41 −0.33 0.98 1.04 −0.07
PPARg 0.90 1.11 −0.20 0.85 0.92 −0.07
Thrombin 2.00 1.93 0.07 1.22 1.15 0.08
TS 1.22 1.48 −0.26 1.27 1.05 0.22
aΔpROC-AUCprep is calculated as pROC-AUC (MOE) – pROC-AUC (Maestro).
bItalicized values represent significant deviations (ΔpROC-AUCprep), while the
non-italicized values are deemed non-significant. cBold values represent the maximum ΔpROC-AUCprep observed (for GOLD: ACE; for Glide: DHFR)
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AUCprep to avoid over-interpreting small changes in
docking performance. Four of the 18 targets did not sig-
nificantly differ between the two preparations. Five of 14
targets (~36 %) showed higher pROC-AUC values for
Maestro prepared data. For the remaining nine targets
(~64 %), Glide produced higher VS performance with
MOE preparation. The screening performance differed
substantially between the preparation schemes for
DHFR, HDAC2 and PNP (Table 1), while the remaining
targets showed only smaller performance differences.
Such screening performance differences can be caused
by various factors, such as (a) the selected protonation/
tautomerization state of the respective protein binding site
residues [26], (b) the protonation/tautomerization states
of the respective input molecules of the dataset [27–29],
and (c) the force field-minimized input conformation of
the respective input molecules of the dataset [31–35]. To
elucidate the influence of (a) and (b), we compared
protonation/tautomerization states of the binding sites
and the molecules and quantified the differences. To get
an idea to which extent (c) differs, we calculated the pair-
wise RMSD of the conformers of the bioactives produced
by the two preparations. A comprehensive summary of
these results can be found in the Supporting Information
(Additional file 1: Table S2 and Table S3).In general, we observed that the screening perform-
ance differences between the two preparations are vari-
able in a target-dependent manner for both docking
programs. We observed that the metal-containing tar-
gets (e.g. ACE and HDAC2) showed relatively high
ΔpROC-AUCprep for both GOLD and Glide. This is not
surprising, since the complexity of the metal-containing
microenvironment of the binding sites is a well-known
phenomenon [29, 38]. The targets that contained higher
numbers of different protonation/tautomerization states
(Additional file 1: Table S2 and Table S3) between the two
preparations (particularly for the bioactives) frequently
show higher ΔpROC-AUCprep for both docking programs
(e.g. ERBB2 and TS). When ignoring the special cases ACE
and HIVPR, there is a certain trend for the remaining 16
datasets, suggesting that difference in protonation/tauto-
merization states of the bioactives and ΔpROC-AUCprep are
correlated (Additional file 1: Figure S1). This implies that
the occurrence of different bioactive protomers and tauto-
mers can be a major contribution to the obscured screening
performance. Interestingly, in several cases (e.g. DHFR and
HDAC2) where the ΔpROC-AUCprep values between Glide
and GOLD differ significantly, a higher number of different
protonation/tautomerization states was found for the bioac-
tives. For a more in-depth analysis, we focus on examining
ACE in more detail.
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We have chosen ACE, as a particular interesting ex-
ample, because for this target we observed the highest
ΔpROC-AUCprep value between MOE and Maestro pre-
pared data for GOLD and a large ΔpROC-AUCprep for
Glide. Therefore, we explored more thoroughly the vari-
ous factors influencing the performance difference of
GOLD. We also conducted a similar analysis on DHFR
that showed the highest ΔpROC-AUCprep for Glide (see
Additional file 1: Figure S2 and Figure S3 in SI).
We compared “matched” vs. “mismatched” docking
experiments to evaluate the contribution of the previ-
ously discussed factors to screening performance differ-
ences. Docking the dataset (bioactives and decoys) into
the protein target prepared with the same preparation
scheme is a “matched” experiment, whereas, different
preparation schemes for target and dataset will be called
a “mismatched” experiment. The results obtained by this
docking procedure are summarized in Fig. 1 and will be
discussed subsequently.Impact of bioactives preparation on the docking rank
and score
From Fig. 1, it is clear that preparation of the bioactives of
ACE had the highest impact on the screening perform-
ance, while different preparation of decoys and target
structure was less crucial. In contrast to the decoy set, the
bioactive set preparation with MOE was always beneficial.
The target structure preparation caused only small per-
formance differences, typically in favor of MOE.
Since the bioactives of ACE showed the highest influ-
ence on the screening performance, we tried to deter-
mine the possible factors responsible for this effect. We
noticed that 35 % of the bioactives (14 out 40) showed
better score-ordered rank for MOE vs. 65 % for Maestro
preparation. Although there are less bioactives that ex-
hibited preference towards MOE preparation, most of
them are found predominantly at very low rank num-
bers, differing substantially from the Maestro rank num-
bers (Fig. 2b). This observation is sufficient to explain
the superior performance of the MOE preparation for
ACE, when using GOLD. To better visualize such per-
turbations in the score-ordered rank of the bioactives
between the two preparations, a box plot of ranks of the
respective bioactives influenced by the two preparations
is shown in Fig. 2a. Interestingly, the maximum differ-
ence in the rank (red arrow) is attributable to a bioactive
exhibiting different protonation states between the two
preparations. The MOE-based protomer reproduced the
key polar interactions with additional favorable H-
bonding contacts in the binding site of ACE (as shown
in Fig. 2c). Therefore, both the rank and the absolute
score (ChemPLP) are superior for this protomer.In general, we observed that ~ 57 % of the bioactives
(23 out 40) showed docking score (fitness) preference to-
wards MOE preparation. To better investigating the ef-
fect of the two preparations on the docking score, we
compared the docking score of the respective bioactives
between the two preparations as shown in Fig. 3b. A
trend of a mutual increase in fitness between the two
preparations is visible; however, a subset of bioactives
clearly favored the MOE preparation. For these high fit-
ness value are reached when preparing them by MOE,
while only mediocre fitness values are obtained for the
respective Maestro-prepared bioactives. This small
group of compounds causes the docking performance to
improve always, when switching the bioactives prepar-
ation from Maestro to MOE in the match vs. mismatch
assessment of Fig. 1. The box plot (Fig. 3a) shows that
the bioactive molecule with the highest docking fitness
when prepared with MOE (blue arrow), also showed the
maximum difference in the docking score (Δ fitness) be-
tween the two preparations. The difference in the fitness
value in this case is not attributable to a difference in
protonation state. It is worthy to mention that this bio-
active is quite flexible (number of rotatable bonds = 13).
This flexibility is a challenging task for the conform-
ational sampling during a docking run to find a reliable
solution [39]. The docking pose of MOE appears to be a
more reliable solution, because it reproduced the correct
interaction pattern in the binding site of ACE, while the
pose obtained by the Maestro-prepared ligand showed a
180° flip and, therefore, lost the key interaction pattern
(as seen in Fig. 3c).
Impact of dataset (bioactives vs. decoys) protonation
Only two of forty ACE bioactives (5 %) showed different
protonation states between MOE and Maestro, while the
decoy set showed 435 differences out of 1200 (36 %) be-
tween the two preparations. The mean value and distri-
bution profile of the score-ordered rank, as well as the
docking score, of the different protomers in the decoys
does not deviate significantly between MOE and Maestro
preparations, as seen from Table 2. These observations
can also be directly seen from the respective pROC plots
in Fig. 4: no changes in the occurrence of the different
decoy protomers are visible in the early recognition re-
gions of the pROC plots. On the other hand, the two
protomers of the bioactives clearly show higher differ-
ences in either the score-ordered rank or the docking
score between the two preparations. Thus, it is unlikely
that the decoys protonation difference between the two
preparations would exert higher impact than the bioac-
tives protonation.
To quantify the impact of the protonation of the data-
set, we conducted a shuffling experiment. The idea of
this experiment is to replace only the protomers selected
Fig. 1 Match vs. mismatch docking assessment. Match vs. mismatch docking assessment of ACE benchmark set. Red and blue crosses represent
Maestro and MOE preparations, respectively
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ated protomers from the other preparation scheme (e.g.
Maestro) while keeping the rest of the input data from
the original preparation (e.g. MOE). This assessment will
result in a new score-ordered list with new values of the
replaced protomers and subsequently a new pROC-
AUC. By calculating the ΔpROC-AUC values after shuf-
fling of the protomers, one is able to evaluate to which
extent the protomers have an impact. Comparing theshuffling impact of both bioactives and decoys proto-
mers, we found that the pROC-AUC values only change
marginally by 0.06 and 0.09 for bioactives and decoys
protomers, respectively (Fig. 5). This highlights that the
different protomers do not give a sufficient explanation
for the initially observed pROC-AUC difference of 0.3.
Upon totally deleting the two bioactives with different
protomers and recalculating the pROC-AUC, we ob-
served only non-significant differences (0.03 for Maestro
Fig. 2 Docking rank comparison between Maestro and MOE preparations (for ACE bioactives). a Box plot illustrating the docking rank of Maestro
and MOE prepared bioactives. The red arrow points towards the bioactive that shows the maximum difference in docking rank. b Scatter plot of
the score-ordered rank of the respective bioactives prepared by Maestro vs. MOE preparation. c 2D representation and the docking pose of the
bioactive showing maximum difference in docking rank between the two preparations. The docking rank and score are illustrated in the figure
for this bioactive
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between MOE and Maestro preparations in this case is
significant (ΔpROC-AUC = 0.26). This observation sug-
gests that the protonation state selection between the
two preparations is only a minor factor and other factors
(e.g. geometric features) should contribute much more
to the observed performance differences.
Impact of bioactives geometric features?
As observed from Fig. 3, a highly flexible bioactive lig-
and showed a maximum fitness difference between the
two preparations. Therefore, to investigate whether the
flexibility of the bioactives is a relevant factor contribut-
ing to the screening performance difference between the
two preparations, we compared the docking score differ-
ence between MOE and Maestro preparations (Δfitness)
to the number of rotatable bonds of the respective bio-
actives. No correlation could be observed when all bio-
actives were included in this comparison (data in
Additional file 1: Figure S5 in SI). Despite the absence of
a general trend, we found that upon isolation of a subsetof outliers (10 bioactives with red dots in Fig. 3b) from
the correlation of the docking scores of MOE vs. Maes-
tro preparations, this isolated subset showed some ten-
dency (Fig. 6) to increase Δfitness with the number of
rotatable bonds (R2 = 0.49) and the number of non-
hydrogen (heavy) atoms (R2 = 0.51). The remaining set
of 30 bioactives shows a striking correlation (R2 = 0.93)
between the docking scores of the MOE and Maestro
preparations. Hence, the docking performance of 75 %
of bioactives is not much influenced by the preparation
scheme, while in the subset (25 %), higher flexibility and
size of the compound can explain the observed differ-
ences partially. Still, it should be noted that the medi-
ocre R2 of about 0.5, implies that flexibility and size not
necessarily increase Δfitness, but that other important
factors can affect the docking score and performance,
e.g. flexible ring conformation and input conformation
geometry.
It is worthy to mention that the majority of the bioac-
tives of ACE (35 out of 40) possess five to seven-
membered flexible ring systems. We observed that all of
Fig. 3 Docking score comparison between Maestro and MOE preparations (for ACE bioactives). a Box plot illustrating the docking fitness (score)
of Maestro and MOE prepared bioactives. The blue arrow points towards the bioactive that shows the maximum difference in docking fitness.
b Scatter plot of the docking fitness of the respective bioactives prepared by Maestro vs. MOE preparation. The red dots represent 10 compounds for
which the docking fitness deviates more strongly between the two preparation schemes. c 2D representation and the docking pose of the bioactive
showing maximum difference in the docking fitness between the two preparations. The best pose of the Maestro-prepared ligand is colored purple,
the best posed of the MOE-prepared ligand is colored green. The docking rank and score are presented for this bioactive as well
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subset of 10 bioactives displayed different selection of
their ring conformations between the two preparations
while only 7 out of the remaining 30 bioactives showed
different selection. This also highlights that the high Δ
fitness values between the two preparations can also be
attributed to the selection of different ring conforma-
tions. Searching the PDB for crystal structure of ligands
in complex with ACE, we found one example (enalapri-
lat) [40] that is part of our subset of 10 bioactives (Fig. 7).
Despite the fact that the co-crystallized pyrrolidine con-
formation of enalaprilat is almost planar and hard to be
predicted, the pyrrolidine conformation produced by
Maestro preparation was – to a certain extent – com-
parable to it and conserved the key polar contacts ofTable 2 Basic statistics showing the distribution of Maestro and MO
MOE
Bioactives (n = 2) Mean SD Min
Rank 85.5 NA 11
Docking score 104.70 NA 91.07
Decoys (n = 435)
Rank 648.6 356.5 8
Docking score 77.33 12.34 39.19enalaprilat’s carboxylate group with the surrounding
polar residues after docking. However, in the MOE prep-
aration, the selected pyrrolidine conformation is differ-
ent and led to an obvious deviation in the placement of
enalaprilat’s carboxylate group, thus, making close con-
tacts with the surrounding polar residues infeasible.
Consequently, the docking score and rank was superior
for Maestro in this case. Although this is just one ex-
ample, it highlights that the ring conformation selection
by the preparation procedures has an important, some-
times crucial, effect on reproducing the correct poses
and, hence, on the screening performance.
To monitor differences in the input conformations be-
tween the two preparations of the bioactives, we calcu-
lated the pairwise RMSD for each bioactive molecule.E protomers for the respective docking runs
Maestro
Max Mean SD Min Max
160 421.5 NA 110 733
118.30 83.97 NA 75.23 92.72
1240 646.7 358.3 7 1240
120.80 75.63 12.28 39.24 112.30
Fig. 4 pROC plots of docking performance of the Maestro and MOE prepared ACE benchmark sets. Red (solid) and orange circles represent
bioactives and decoys protomers, respectively. The 2D structural representation of the protomers of the respective bioactives is shown in
Additional file 1: Figure S4 in SI
Fig. 5 Shuffling vs. no shuffling assessment. Shuffling vs. no shuffling assessment for Maestro and MOE protomers showing the impact of the
protomers of the bioactives vs. decoys
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Fig. 6 Docking score behavior of ACE bioactives. a Scatter plot of the docking fitness of the 30 bioactives prepared by Maestro vs. MOE after
isolating a subset of 10 outliers. b Scatter plot of the docking fitness of the subset of isolated 10 outliers plotted against their number of rotatable
bonds and c plotted against their respective number of non-hydrogen (heavy) atoms
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RMSD values between their input conformations (R2 =
0.52, see Additional file 1: Figure S6 in SI). This certainly
makes sense, since it is challenging for the two force
fields to find closely related energy minima, when mo-
lecular size and flexibility increases. However, we did not
observe any reasonable trend (R2 always below 0.2) be-
tween the pairwise RMSD of the bioactive molecules
and the Δfitness in any of the 18 datasets. It is evident
from other studies in the literature [31, 32] that small
changes in the input conformation of the molecule (e.g.
torsional angles and bond lengths) can affect the docking
performance to a vast extent. Thus, we cannot rule out
that differences in the way the input conformations were
generated in the two procedures will cause a significant in-
fluence on the different docking performances observed.Fig. 7 Impact of flexible ring conformation (ACE bioactives). Conformation
(PDB code: 1UZE) compared to docking results achieved after ligand prepa
the docked poses of enalaprilat by GOLD. c 2D representation of enalaprilaImpact of decoys preparation
Although the decoys showed less impact on the screen-
ing performance compared to the bioactives, we have
scrutinized the differences between the two preparations
in more detail. Figure 8a highlights that there is a mu-
tual increase in the docking score (fitness) of the re-
spective decoy between MOE and Maestro preparations
(R2 = 0.83). This suggests that the Δfitness values be-
tween the two preparations are quite small. Generally,
we observed that 60 % of the decoys (720 out 1200)
showed docking score preference toward the MOE prep-
aration scheme. This can explain the fact that the dock-
ing performance (i.e. pROC-AUC) always improved
when switching the decoys preparation from MOE to
Maestro in the match vs. mismatch assessment in Fig. 1,
since higher docking scores for the majority of theof enalaprilat – (crystal structure in yellow sticks) in complex with ACE
ration with Maestro (a) and MOE (b). Purple and green sticks indicate
t with docking score and rank difference indicated below
Fig. 8 Docking score and rank behavior of the ACE decoys. a Scatter
plot of the docking fitness of the respective 1200 decoys prepared
by Maestro vs. MOE preparation. b Scatter plot of the global docking
rank of the respective 1200 decoys prepared by Maestro vs. MOE
preparation. The colored dots and circles are the decoys that
showed Δdocking rank > 500. Colored dots represent decoys that
show different protonation (red), tautomerization (blue) or ring
conformations (green) between the Maestro and MOE preparations,
whereas the red circles represent decoys that show none of the
previous differences
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ation between the bioactives and decoys, and as a conse-
quence lower pROC-AUC values for experiments with
MOE prepared decoys.
Transforming the docking score information into the
global docking rank (i.e. including the bioactives’ ranks)
showed more scattering of some decoys around the fit-
ted line (R2 = 0.81) for the rank correlation, as seen in
Fig. 8b. For getting some answers about the possible fac-
tors that affected the difference in the docking rank be-
tween the two preparations for the decoys, we firstlooked at the most obvious outliers. Thus, we applied a
cutoff value of the docking rank difference of 500 (i.e.
Δdocking rank > 500) bearing in mind that the max-
imum Δdocking rank difference observed for the bioac-
tives was 573. We ended up with 13 decoys that showed
a Δdocking rank between the two preparations above
the cutoff. In summary these 13 decoys exhibit the fol-
lowing properties: (a) four decoys showed differences in
the protonation state, (b) one decoy had an altered
tautomer state, (c) two decoys deviated in their ring con-
formations, and (d) six decoys did not show any of pre-
vious factors, but three of those had a rather high
number of rotatable bonds (more than 8). It is note-
worthy that the maximum Δdocking rank of the decoys
is attributable to a difference in protonation state be-
tween the two preparations. Generally, we noticed that
49 % of the decoys (586 decoys) showed better ranks
after the MOE preparation, while 51 % had better ranks
after the Maestro preparation. Because this ratio is al-
most exactly 1:1, it does not provide any clues for under-
standing why the docking performance for ACE is
superior in case of the MOE preparation. This indicates
that the docking rank of the bioactives is certainly much
more important for the overall result than the docking
rank of the decoys. We conclude that similar aspects as
discussed before for the bioactives cause differences be-
tween the two preparations, but the overall influence of
such differences in the decoys is significantly inferior.
Impact of target structure preparation
Interestingly, the preparation schemes yielded different
protonation states of binding site residues His353 and
Asp415 as shown in Fig. 9. Unlike Maestro preparation,
MOE protonated the residues His353 and Asp415 in the
binding site of ACE. The charged nitrogen of HIS353
pointed towards the co-crystallized ligand. Although,
Asp415 is located not in close proximity of the zinc ion
and the co-crystallized ligand, it could be accessible by
larger molecules, as shown in Fig. 9c. These differences
between MOE and Maestro protonation for these resi-
dues contribute to a difference in hydrogen bonding
capabilities of the binding site. Another important factor
for target-dependent screening performance differences
is the complexity of the microenvironment of metal-
containing targets [29, 38]. Interactions of ligands with
metal ions can be recognized by the docking program
only for certain ligand protomers or tautomers [38]. This
phenomenon is not trivial to handle since selecting a
reasonable protomer/tautomer in an automated fashion
is not trivial.
Score normalization
The employed docking tools (GOLD and Glide) in this
study utilize empirical scoring functions. Empirical
Fig. 9 Impact of the protein target preparation. Binding site of ACE (PDB code: 1UZE) prepared by Maestro (a) and MOE (b). The co-crystallized
ligand is represented as yellow sticks. Asp415 and His353 show different protonation states in (a) and (b). c A relatively large bioactive compound
(purple sticks) forms hydrogen bonds with Asp415 in the binding site prepared with Maestro
Fig. 10 Score normalization behavior of ACE bioactives. a Scatter
plot of the docking fitness of the respective bioactives prepared by
MOE vs. number of non-hydrogen (heavy) atoms, and b after
normalizing the docking fitness by N1/2. The dashed line represents
the mean value of the normalized fitness
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a dependence on molecular weight. This results in a bias
toward heavier molecules being ranked at the top of a
score-ranked list of molecules [41, 42], as can also be
seen for the bioactives (e.g. MOE preparation) of the
ACE example, in Fig. 10a. Weighing the docking score is a
well-known strategy to reduce the molecular weight bias
in VS [39]. For this we divided the docking score by the
square root of the number of heavy atoms (N1/2) or the
cubic root of the squared number of heavy atoms (N2/3)
[41]. For ACE, normalizing fitness values of the bioactives
(e.g. MOE preparation) produced a random distribution
around their mean value. This eliminated the biased distri-
bution of their original values as well as enhanced the
screening performance, as shown in Table 3.
In general, we found that the GOLD screening per-
formance for many datasets (see Table 3) was improved
when applying the docking score normalization. In con-
trast, the Glide docking performance was reduced for al-
most all benchmark sets when applying the score
normalizations (data in Additional file 1: Table S4 in SI).
We found that the N2/3 normalization, which empha-
sizes the number of heavy atoms more strongly than
N1/2 in the final score, yielded worse performance re-
sults than the N1/2 normalization. Interestingly, GOLD
docking into HSP90 with the MOE preparation dis-
played a pROC-AUC < 0.434 – worse than random per-
formance – with the original setup, but gave a
significantly improved enrichment for both N2/3 and
N1/2 normalizations and the screening performance was
shifted to be better than random (>0.434). It is obvious
that for several targets with a larger average size (e.g.
average number of heavy atoms or molecular weight) of
their datasets (e.g. HIV1PR and ERBB2), their perform-
ance after normalization was penalized quite signifi-
cantly, and vice versa for targets that show a relatively
small average size (e.g. PNP), their performance after
normalizations has been improved (Table 3).
Table 3 Overview of the screening performance based on the normalized scores obtained by GOLD docking after MOE preparation.
Further data on the normalization of the docking performances for Glide and GOLD after MOE and Maestro preparation are
available in Additional file 1: Table S4 in the Supporting Information
Target N2/3 ΔpROC-AUCN
a N1/2 ΔpROC-AUCN MW
c mean per dataset NHAd mean per dataset
ACE 1.76 0.21b 1.81 0.26 398.7 27.6
ACHE 0.64 −0.07 0.71 −0.01 398.6 28.6
ADRB2 0.76 0.02 0.80 0.07 425.5 29.7
CATL 0.55 −0.23 0.63 −0.16 482.0 33.9
DHFR 1.07 0.32 1.02 0.27 385.8 26.8
ERBB2 1.00 −0.85 1.34 −0.51 473.8 33.8
HDAC2 0.93 −0.09 1.03 0.00 388.4 27.5
HIVPR 0.75 −0.70 0.97 −0.48 584.3 41.2
HSP90 0.58 0.16 0.55 0.12 424.1 29.3
JAK3 0.76 −0.02 0.82 0.04 404.1 29.0
JNK2 0.68 −0.09 0.71 −0.05 413.5 29.7
MDM2 0.35 −0.16 0.40 −0.11 554.7 36.4
P38 0.53 0.04 0.53 0.04 383.1 27.7
PI3KG 1.02 0.02 1.17 0.16 412.3 29.4
PNP 1.22 0.24 1.24 0.26 269.1 18.9
PPARg 0.83 −0.02 0.89 0.04 463.6 32.6
Thrombin 1.12 −0.11 1.20 −0.03 479.7 33.5
TS 1.06 −0.21 1.26 −0.01 415.3 29.5
aΔpROC-AUCN is calculated as (pROC-AUC of normalized – pROC-AUC of original). pROC-AUC of original values are present in Table 1.
bItalicized values
demonstrate significant ΔpROC-AUCN (i.e. -0.05 > ΔpROC-AUCN > +0.05) where negative and positive values highlight inferior and improved performance by
normalization, respectively. Regular-formatted values demonstrate non-significant change by normalization. cMW is the molecular weight. dNHA is the number
of heavy atoms
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medicinal/computational chemists may test the perform-
ance of the N1/2 normalization for GOLD (ChemPLP),
whereas for Glide, no normalization appears to be re-
quired. This may not be surprising, since the ChemPLP
scoring function of GOLD has been originally developed
for pose prediction purposes [43, 44], while Glide SP
had been optimized for screening enrichment and dock-
ing accuracy [45, 46].
Methods
Preparation of targets
Maestro preparation scheme: For each crystal structure
the coordinates were retrieved from the Protein Data
Bank (PDB) in our dataset. A comprehensive list of PDB
codes is given in Additional file 1: Table S1. The prepar-
ation of the original PDB files was conducted by assign-
ing bond orders, adding explicit hydrogens, creating
zero-order bonds to metals, and converting seleno-
methionines to methionines using the Protein Prepar-
ation Wizard in Maestro (version 9.1) [47]. Redundant
and identical macromolecule chains with non-essential
co-factors, ions, water molecules and ligands were dis-
carded. Exceptions were made for (PDB code: 1i00) with a
co-substrate in the ligand binding site, and for structuresthat contained metal ions (e.g. Zn2+, and Mg2+) in their lig-
and binding pocket (PDB code: 1uze and 3max). The metal
binding states were generated at pH 7.0 by Epik [48, 49].
H-bond network optimization, protonation and tautomeric
states of Asp, Glu, Arg, Lys and His were sampled by “Pro-
tAssign” in the standard mode. Possible alternative orienta-
tions of Asn and Gln residues were also generated. The
native geometry of the binding sites was preserved without
in-place ligand-protein minimization. Prepared structures
were saved as MAE and PDB files. The MAE files were
used for Glide [45, 46] (version 5.6) docking, the PDB files
were used for GOLD (version 5.1) docking [50–53].
MOE preparation scheme: Again, identical and redun-
dant protein chains with non-essential co-factors, ions,
water molecules and ligands were discarded while co-
substrates, and metal ions in the ligand binding site were
preserved. Bond orders, formal charges and explicit hy-
drogens were added to the complex structure. Subse-
quently, protonation and tautomeric states were
generated, and optimization of the H-bond network of
the protein-ligand complexes was performed with the
MOE ‘Protonate 3D’ function at standard settings (T =
300 K, pH = 7.0, ionic strength I = 0.1 mol/l). Prepared
structures were saved as pdb files and then used for
Glide and GOLD. Again, the native geometry of the
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protein minimization. An overview of the procedures
employed by Maestro and MOE schemes is shown in
Table 4.
Preparation of DEKOIS 2.0 datasets
Maestro preparation scheme: All molecules of the data-
sets were prepared by LigPrep (version 2.4) [54]. The
molecules were minimized using the OPLS-2005 force
field. The protonation state was generated at pH 7.0 for
each molecule. The specified stereoconfiguration of all
bioactives and decoys of the datasets was retained. All
prepared molecules were saved as SD files for Glide and
GOLD docking. MOE preparation scheme: “molecule
wash” function was used to generate meaningful proton-
ation states by deprotonating strong acids and protonat-
ing strong bases. Energy minimization of all molecules
was then performed using the MMFF94x force field at a
gradient of 0.01 RMSD (i.e. if the gradient falls below
RMSD, the minimization stops). Existing chirality was
preserved and partial charges were calculated according
to the standard parameters of the force field.
We conducted the pairwise RMSD calculation for the
respective molecules of the datasets between Maestro
and MOE schemes by employing in-house python script
applying the “smart_rms” function of GOLD.
Docking experiments
The docking runs were performed with Glide and
GOLD at the default settings. Only the best pose per
molecule was retrieved for the molecules of the datasets
from the docking and pROC-AUC values were calcu-
lated thereof. For Glide (version 5.6) docking, we gener-
ated the receptor grid-box by default settings, with an
approximate size (on average) 20 x 20 x 20 angstroms
for most of the targets. We conducted the standard pre-
cision docking mode (SP) and also considered Epik state
penalties for metal-containing binding sites. By default,
the cutoff for keeping initial docking poses was 100.0Table 4 Overview of Maestro and MOE preparation schemes for tar
preparing the input
1) Targets preparation
Adding hydrogens and H-bond optimization
Asn and Gln flipping
Protonation/tautomerization states of Asp, Glu, Arg, Lys and His
Number of protomer/tautomer retrieved for Asp, Glu, Arg, Lys and His
2) Dataset (bioactives and decoys) preparation
Minimization
Number of protomer/tautomer retrieved
Input chirality retainedkcal/mol (relative to the best scored initial pose). The
best five final docking poses per molecule were selected
for post-docking minimization within Glide. For GOLD
(version 5.1) docking, residues of the binding site were
defined by specifying the crystal structure ligand coordi-
nates and using a cutoff radius of 10 Å, with the ‘detect
cavity’ option enabled. The scoring function used for
GOLD docking experiments was ChemPLP. The search
efficiency of the genetic algorithm was kept at the stand-
ard 100 % setting. The docking was early terminated
when the top three solutions were within 1.5 Å RMSD.
In order to avoid over-interpreting small changes in
the docking performance and to account for the heuris-
tic nature of the docking tools, we defined the “safety
margin” of ±0.05 ΔpROC-AUCN below which it is con-
sidered non-significant in the normalization task. This
ΔpROC-AUCN is calculated as:
ΔpROC−AUCN ¼ pROC−AUC normalizedð Þ
−pROC−AUC originalð Þ
Conclusion and outlook
We have shown in this study that application of compar-
able setups for the preparation of targets, bioactives and
decoys by different modeling packages (Maestro or
MOE) affected the screening performance of Glide and
GOLD in the majority of the investigated targets. These
differences in the screening performance are attributable
to multiple factors, such as the different selection of: (a)
the protonation/tautomerization state of the target’s
binding site residues and molecules of the datasets, and
(b) the input geometry of the prepared molecules due to
the intrinsic differences between the force field parame-
ters of both preparation schemes. Match versus mis-
match docking runs of the ACE dataset as a case
example demonstrated that the preparation of the bio-
active molecules has the highest impact on the screening











Fig. 11 Behavior of the score normalization of GOLD docking (MOE
preparation) with the mean number of heavy atoms per bioactive
set. a Scatter plot of ΔpROC-AUCN vs. the mean number of heavy
atoms (N) per bioactive set for N1/2, and b for N2/3. The grey region
of ΔpROC-AUCN indicates the non-significant margins (±0.05)
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shuffling experiment. In both cases the importance of
the protonation state differences seemed small, yet
slightly more relevant for the bioactive molecules. Hav-
ing a look at the docking rank and score of the respect-
ive bioactive between the two preparations, we found
that the maximum difference of the rank is attributable
to a bioactive ligand that showed a difference in its
protonation state between the two preparations. The
maximum fitness difference (Δfitness) was caused by a
bioactive ligand that showed a highly flexible structure.
Analyzing the geometric features as possible impact fac-
tors on the screening performance difference, we found
that the flexibility features (e.g. number of rotatable
bonds and number of heavy atoms) showed a reasonable
correlation (R2 = 0.49 and 0.51, respectively), with the
Δfitness for a subset of ten bioactives, which exhibited
the highest deviations in the fitness values. For the
remaining 30 bioactives, fitness values between the two
preparations were highly similar (R2 = 0.93). Among the
geometric features identified is also the impact of select-
ing different conformations of flexible rings in bioactives
as well as the input conformation of the dataset for
docking. Analysis of the decoys behavior between the
two preparation schemes agreed widely with the general
findings observed for the bioactives.
We recommend that computational/medicinal
chemists should evaluate the available docking pro-
grams with several different preparation/docking
setups – e.g. using DEKOIS 2.0 – to retrieve the best
possible performance which then can be used for an
actual SBVS effort. In addition, score normalization
strategies eliminated the biased fitness shown by
GOLD for the larger bioactives of ACE. Generalizing
these normalization strategies on the 18 targets, we ob-
served improved performances for the majority of the
GOLD docking results, whereas normalization led to
detrimental performances for the majority of Glide
docking runs. Therefore, we recommend that compu-
tational/medicinal chemists should employ score
normalization strategies for GOLD (ChemPLP) espe-
cially using a normalization factor of N1/2 for bioactive sets
with a mean number of heavy atoms of 30 or below (see
Fig. 11). In particularly these cases, we have observed an
increased chance that pROC-AUC values are improved.
In none of the studied datasets of this group,
normalization by a factor of N1/2 produced signifi-
cantly worse results. However, for bioactive sets with a
larger mean number of heavy atoms, the risk of detri-
mental effects on the pROC-AUC values is obvious.
For using a normalization factor of N2/3, we observed a
higher chance for improvements below a mean number
of heavy atoms of 28 and a high risk for inferior per-
formance above a mean number of heavy atoms of 29.We propose that these numbers could be used as
rough guidelines and should be validated by using
more benchmark sets in the future. In general, testing
normalization strategies for empirical scoring func-
tions that have been mainly optimized for pose predic-
tion purposes will be useful.
Elucidating the effect of two different preparations
on the screening performance and deconstructing the
possible factors behind these performance differences
is certainly useful for making reasonable decisions in
virtual screening campaigns. In addition, another im-
portant factor for understanding benchmarking results
can be the composition of the set of bioactives with re-
spect to the frequent occurrence of similar scaffolds or
common substructures. For achieving this, we aim at
studying the impact of the two preparation schemes on
the chemotype recognition during the docking process
in a subsequent publication.
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Additional file 1: (Supporting Information): Detailed insights with
additional Tables and Figures. We provide additional Tables and
Figures to give more detailed insights into: Overview of the targets
description (Table S1), Overview of the difference in protonation/
tautomerization states of the binding site residues of the respective
targets prepared by the two preparations (Table S2), Overview of
protonation/tautomerization state difference between the two
preparations as well as the average number of the rotatable bonds,
heavy atoms and pairwise RMSD per target (Table S3), Overview of the
normalization strategies on GOLD and Glide dockings on MOE and
Maestro preparation schemes (Table S4), Scatter plot of the correlation
between the percentage difference in protonation/tautomerization states
of the bioactives and the absolute value of the ΔpROC-AUC (Figure S1),
Binding site of DHFR showing the difference between the two preparations
and the match vs. mismatch assessment for DHFR benchmark sets using
Glide (Figure S2), Overview of the protonation/tautomerization states
selected by the two preparations for DHFR bioactive set (Figure S3),
Overview of the protonation/tautomerization states selected by the two
preparations for ACE bioactive set (Figure S4), Scatter plot of the correlation
between Δ fitness vs. number of rotatable bonds (Figure S5), and scatter
plot of the correlation between the number of heavy atoms and the
pairwise RMSD of the two conformations resulted from the two preparations
for ACE bioactives (Figure S6).
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